A versatile international business leader with deep expertise in life sciences. Kim's career showcases rare agility — seamlessly transitioning between commercial and operations leadership, across industries, geographies, and therapeutic areas. She has led multi-region revenue delivery, managed complex portfolios, and driven digital transformation from Salesforce adoption to omnichannel patient and physician engagement.
From architecting supply chains delivering billions in medicines to leading commercial franchises across Europe, Canada, and emerging markets, Kim brings operational rigor, strategic vision, and a relentless focus on patient outcomes. Her work spans hematology, plasma-derived therapies, immunology, and rare disease — with full P&L ownership, budget stewardship, and revenue accountability at every level.
Full P&L ownership across Europe, Canada, and emerging markets — driving revenue delivery and commercial accountability for multi-hundred-million-dollar portfolios.
End-to-end supply chain architecture — from S&OP and demand planning to distribution, ensuring patients receive medicines on time.
Driving digital adoption from Salesforce and Veeva to omnichannel engagement strategies.
Stewardship of complex product portfolios and budgets, balancing investment priorities with growth targets and lifecycle planning.
Go-to-market strategy, brand lifecycle management, launch activation, and market access across diverse regulatory environments.
Expertise in hematology, immunology, rare disease, and plasma-derived therapies across global markets.
Building and chairing cross-functional taskforces spanning Medical, Market Access, Digital, Finance, and country teams in complex matrix organizations.
Expanding patient access and commercial presence across growth markets, navigating unique regulatory, cultural, and distribution challenges.
I'm always happy to connect on new opportunities — whether it's exploring strategic partnerships, speaking engagements, advisory roles, or simply exchanging ideas about the future of global healthcare. Let's start a conversation.
View LinkedIn Profile